Research from National Autonomous University of Mexico (UNAM) Reveals New Findings on Antidiabetic Agents (Longitudinal assessment of SNPs rs72552763 and rs622342 in SLC22A1 over HbA1c control among Mexican-Mestizo diabetic type 2 patients).

Předmět:	TYPE 2 diabetes SINGLE nucleotide polymorphisms HYPOGLYCEMIC agents REPORTERS & reporting GLYCEMIC control
Zdroj:	Diabetes Week; 10/14/2024, p313-313, 1p
Abstrakt:	A recent study conducted by researchers at the National Autonomous University of Mexico (UNAM) examined the impact of certain genetic variations on the response to metformin therapy in Mexican-Mestizo patients with type 2 diabetes. The study found that specific single nucleotide polymorphisms (SNPs) in the SLC22A1 gene were associated with a shorter time to non-control of blood glucose levels. These findings suggest that these genetic variations could serve as biomarkers for predicting therapeutic response in this population. The study highlights the importance of considering genetic factors in personalized medicine approaches for diabetes treatment. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu